MedTech Intelligence, Due Diligence

There’s More to Due Diligence Than You Think

By MedTech Intelligence Staff
MedTech Intelligence, Due Diligence

A strategy that pulls in regulatory, quality, clinical, reimbursement, marketing, compliance, legal and finance is required.

The challenges in conducting due diligence go far beyond financial modeling and mapping out product markets. It’s not simply, “we want to do this because we want to make a lot of money.” With last-minute surprises bound to arise, companies must pull together all critical departments, from regulatory and quality to marketing, legal, clinical and finance in order to prepare.

Med Tech Due Diligence | July 14–15, 2016 | Boston, MA | Registration Limited! LEARN MORE MedTech Intelligence is announcing a new conference on Due Diligence, which will be held July 14–15 in Boston. Attendees will learn how to manage, organize and coordinate the entire due diligence process, factors critical to the deal, and how to provide meaningful input to the C-suite from industry experts who have gone through the process themselves.

Featured sessions include:

  • Valuation
  • Regulatory and Quality
  • Clinical Evidence
  • Reimbursement
  • Sales & Marketing
  • Compliance Issues
  • Supply Chain Evaluation
  • Products Liability
  • People and Culture

Seating is limited to 30 registrants, and there will not be a virtual attendance option.

Related Articles

  • Dan Golder, Impact Advisors

    Standalone best-of-breed Enterprise Asset Management (EAM) systems have historically been leveraged to help solve the transactional needs of clinical engineering, IT and facilities. Yet few organizations are currently capitalizing on the wealth of data generated from these systems. In this…

About The Author

MedTech Intelligence